Please login to the form below

PMBCL

This page shows the latest PMBCL news and features for those working in and with pharma, biotech and healthcare.

Meanwhile, Gilead reported $216m in first-half sales from DLBCL and another NHL variant called primary mediastinal large B-cell lymphoma (PMBCL).

NHS chief pledges CAR-T support, but asks for pricing restraint

primary mediastinal B-cell lymphoma (PMBCL) and transformed follicular lymphoma (TFL).
Novartis files CAR-T therapy CTL109 in Europe

Kite was the first to file its new therapy in Europe, seeking approval in August for DLBCL, transformed follicular lymphoma (TFL), and primary mediastinal B-cell lymphoma (PMBCL) in adults ineligible
Kite starts EU trial of lead CAR-T therapy

Adult patients with DLBCL, PMBCL and TFL will be enrolled in the trial. ... Kite is currently enrolling adult patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), primary mediastinal B-cell lymphoma (PMBCL), and transformed follicular
Kite files first CAR-T candidate in Europe

cell lymphoma (PMBCL) who are ineligible for autologous stem cell transplant.
Kite Pharma soars after positive CAR-T data in lymphoma

B-cell lymphoma (PMBCL) - on the strength of the trial results.

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Add my company

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

OPEN Health delivers over 250 virtual activities during COVID-19 – A clear path forward: ...
Can eLearning improve patient recruitment and retention?: Some patients will still want to read pages of informed consent forms before joining a clinical trial, or want timely updates on paper rather than a notification on their phone....
How Far Do You Want To Go?: Join OPEN Health's virtual careers event on Tuesday 10th November, 15:00–17:00 GMT and discover where a career in medical communications could take you…...